Skip to main content
. 2023 Mar 27;110(6):701–709. doi: 10.1093/bjs/znad065

Table 3.

Patterns of care for patients having curative surgery for oesophagogastric cancer by time period and tumour site

2012–2014 2014–2016 2016–2018 2018–2020
Oesophagectomy, n 3071 3078 2765 2557
Neoadjuvant therapy, n (%) 2151 (70.0) 2090 (67.9) 1904 (68.9) 1878 (73.5)
Main procedure
ȃThoracoabdominal 309 (10.1) 283 (9.2) 181 (6.6) 161 (6.3)
ȃTwo-phase 2517 (82.0) 2473 (80.3) 2369 (85.7) 2221 (86.9)
ȃThree-phase 144 (4.7) 197 (6.4) 153 (5.5) 136 (5.3)
ȃTranshiatal 101 (3.3) 125 (4.1) 62 (2.2) 39 (2.5)
Surgical access
ȃOpen 1675 (58.5) 1639 (57.7) 1367 (51.7) 1150 (47.0)
ȃHybrid 771 (26.9) 867 (30.5) 789 (29.9) 745 (30.4)
ȃLaparoscopic completed 290 (10.1) 256 (9.0) 412 (15.6) 450 (18.4)
ȃLaparoscopic converted 129 (4.5) 81 (2.9) 75 (2.8) 65 (2.7)
ȃRobotic 0 0 <5 37 (1.6)
ȃMissing 206 235 120* 110
Gastrectomy 1735 1606 1481 1357
Neoadjuvant therapy 801 (46.2) 673 (41.9) 618 (41.7) 695 (51.2)
Main procedure
ȃTotal gastrectomy 794 (45.8) 673 (41.9) 700 (42.3) 640 (47.2)
ȃExtended gastrectomy 122 (7.0) 143 (8.9) 127 (8.6) 125 (9.2)
ȃProximal 28 (1.6) 37 (2.3) 24 (1.6) 16 (1.2)
ȃDistal gastrectomy 733 (42.3) 714 (44.5) 587 (39.6) 556 (41.0)
ȃOther 58 (3.4) 39 (2.5) 43 (2.9) 20 (1.5)
Surgical access
ȃOpen 1481 (85.4) 1346 (83.8) 1213 (82.0) 1079 (80.1)
ȃLaparoscopic completed 207 (11.9) 219 (13.6) 237 (16.0) 248 (18.4)
ȃLaparoscopic converted 47 (2.7) 41 (2.6) 29 (2.0) 20 (1.5)
ȃRobotic 0 0 0 <5
ȃMissing 0 0 2 10*
Surgical volumes
ȃNHS organizations performing surgery 56 66 51 57
ȃMedian number of patients per organization over 2 years (i.q.r.) 84.5 (28–129.5) 72 (1–113) 87 (36–127) 64 (2–105)

Values are n (%) unless otherwise stated. Data suppression applied to small numbers (<5) and percentages calculated treating suppressed values as 0. *Rounded to the nearest 5. NHS, National Health Service; i.q.r., interquartile range.